Kavalcı Kol Başak, Boşnak Güçlü Meral, Baytok Ece, Yılmaz Demirci Nilgün
Pilot Health Coordinatorship, Kırşehir Ahi Evran University, Kırşehir, Türkiye.
Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation, Gazi University, Çankaya, Ankara, Türkiye.
Physiother Theory Pract. 2025 Feb;41(2):275-288. doi: 10.1080/09593985.2024.2327534. Epub 2024 Mar 12.
Pulmonary involvement is prevalent in patients with coronavirus disease 2019 (COVID-19). Arterial hypoxemia may reduce oxygen transferred to the skeletal muscles, possibly leading to impaired exercise capacity. Oxygen uptake may vary depending on the increased oxygen demand of the muscles during submaximal and maximal exercise.
This study aimed to compare muscle oxygenation during submaximal and maximal exercise tests in patients with post-COVID-19 syndrome with pulmonary involvement.
Thirty-nine patients were included. Pulmonary function (spirometry), peripheral muscle strength (dynamometer), quadriceps femoris (QF) muscle oxygenation (Moxy® device), and submaximal exercise capacity (six-minute walk test (6-MWT)) were tested on the first day, maximal exercise capacity (cardiopulmonary exercise test (CPET)) was tested on the second day. Physical activity level was evaluated using an activity monitor worn for five consecutive days. Cardiopulmonary responses and muscle oxygenation were compared during 6-MWT and CPET.
Patients' minimum and recovery muscle oxygen saturation were significantly decreased; maximum total hemoglobin increased, heart rate, blood pressure, breathing frequency, dyspnea, fatigue, and leg fatigue at the end-of-test and recovery increased in CPET compared to 6-MWT ( < .050). Peak oxygen consumption (VO) was 18.15 ± 4.75 ml/min/kg, VO; percent predicted < 80% was measured in 51.28% patients. Six-MWT distance and QF muscle strength were less than 80% predicted in 58.9% and 76.9% patients, respectively.
In patients with post-COVID-19 syndrome with pulmonary involvement, muscle deoxygenation of QF is greater during maximal exercise than during submaximal exercise. Specifically, patients with lung impairment should be evaluated for deoxygenation and should be taken into consideration during pulmonary rehabilitation.
2019冠状病毒病(COVID-19)患者中肺部受累很常见。动脉血氧不足可能会减少输送到骨骼肌的氧气,这可能导致运动能力受损。在次最大强度和最大强度运动期间,摄氧量可能会因肌肉增加的氧气需求而有所不同。
本研究旨在比较有肺部受累的COVID-19后综合征患者在次最大强度和最大强度运动测试期间的肌肉氧合情况。
纳入39例患者。第一天测试肺功能(肺活量测定)、外周肌肉力量(测力计)、股四头肌(QF)肌肉氧合(Moxy®设备)和次最大运动能力(6分钟步行试验(6-MWT)),第二天测试最大运动能力(心肺运动试验(CPET))。使用连续佩戴5天的活动监测器评估身体活动水平。比较6-MWT和CPET期间的心肺反应和肌肉氧合情况。
患者的最低和恢复肌肉氧饱和度显著降低;最大总血红蛋白增加,与6-MWT相比,CPET结束时和恢复时的心率、血压、呼吸频率、呼吸困难、疲劳和腿部疲劳增加(<0.050)。峰值摄氧量(VO)为18.15±4.75 ml/min/kg,51.28%的患者VO;预测百分比<80%。58.9%和76.9%的患者6-MWT距离和QF肌肉力量分别低于预测值的80%。
在有肺部受累的COVID-19后综合征患者中,QF的肌肉脱氧在最大强度运动期间比在次最大强度运动期间更大。具体而言,肺部受损患者应评估其脱氧情况,并在肺康复期间予以考虑。